Detalhe da pesquisa
1.
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.
PLoS Pathog
; 16(12): e1009167, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33347498
2.
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.
PLoS Pathog
; 16(4): e1008477, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251475
3.
Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
Front Immunol
; 11: 1231, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32625211
4.
Emergence of CD4+ and CD8+ Polyfunctional T Cell Responses Against Immunodominant Lytic and Latent EBV Antigens in Children With Primary EBV Infection.
Front Microbiol
; 9: 416, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29599759